Literature DB >> 1555997

Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.

E Hiyama1, K Hiyama, T Yokoyama, T Ichikawa, Y Matsuura.   

Abstract

Telomeres are the physical ends of eukaryotic chromosomes. In view of reports of the reduction of telomeric repeats in human malignant tumors, we measured the lengths of telomeric repeats in 55 primary neuroblastomas. The average lengths of telomeric repeats in these tumors fell in a wide range (from 1.1 kb to more than 23 kb) relative to those in ganglioneuromas and normal peripheral mononuclear cells. The reduction of telomeric repeats was significantly correlated with advanced stages of tumor development, poor prognosis, and increased S-phase fractions in tumor cells. On the other hand, three cases of Stage IV-S tumors showed the reduction of telomeric repeats and low percentage of S-phase fractions. These Stage IV-S patients had a good prognosis with spontaneous regression of metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555997      PMCID: PMC5918785          DOI: 10.1111/j.1349-7006.1992.tb00081.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

Review 1.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

2.  N-myc gene amplification and other prognosis-associated factors in neuroblastoma.

Authors:  E Hiyama; T Yokoyama; T Ichikawa; T Ishii; K Hiyama
Journal:  J Pediatr Surg       Date:  1990-10       Impact factor: 2.545

3.  Spontaneous regression of neuroblastoma.

Authors:  A E Evans; J Gerson; L Schnaufer
Journal:  Natl Cancer Inst Monogr       Date:  1976-11

4.  Do infants with stage IV-S neuroblastoma need treatment?

Authors:  A E Evans; E Baum; R Chard
Journal:  Arch Dis Child       Date:  1981-04       Impact factor: 3.791

5.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

6.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

7.  Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.

Authors:  H Shimada; J Chatten; W A Newton; N Sachs; A B Hamoudi; T Chiba; H B Marsden; K Misugi
Journal:  J Natl Cancer Inst       Date:  1984-08       Impact factor: 13.506

8.  Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients.

Authors:  E Hiyama; K Hiyama; T Yokoyama; T Ishii
Journal:  J Pediatr Surg       Date:  1991-07       Impact factor: 2.545

Review 9.  Complete pathologic maturation and regression of stage IVS neuroblastoma without treatment.

Authors:  D Haas; A R Ablin; C Miller; S Zoger; K K Matthay
Journal:  Cancer       Date:  1988-08-15       Impact factor: 6.860

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  16 in total

1.  Possibility of selection of chondrogenic progenitor cells by telomere length in FGF-2-expanded mesenchymal stromal cells.

Authors:  S Yanada; M Ochi; K Kojima; P Sharman; Y Yasunaga; E Hiyama
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

2.  Alterations of telomere length in human brain tumors.

Authors:  Majid Kheirollahi; Masoud Mehrazin; Naser Kamalian; Parvin Mehdipour
Journal:  Med Oncol       Date:  2010-04-07       Impact factor: 3.064

3.  Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.

Authors:  Matthias Krams; Barbara Hero; Frank Berthold; Reza Parwaresch; Dieter Harms; Pierre Rudolph
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

4.  Robertsonian translocation as a result of telomere shortening during replicative senescence and immortalization of bovine oviduct epithelial cells.

Authors:  Ken Murata; Kei Hanzawa; Fumio Kasai; Masakatsu Takeuchi; Tomoko Echigoya; Shigeru Yasumoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-09       Impact factor: 2.416

5.  Telomerase activity in human ovarian carcinoma.

Authors:  C M Counter; H W Hirte; S Bacchetti; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification.

Authors:  Eiso Hiyama; Hiroaki Yamaoka; Satoshi Kondo; Akihiro Yoneda; Tatsuro Tajiri; Masahiro Fukuzawa; Masahiko Sugiyama; Yutaka Hayashi; Fumiaki Sasaki; Megu Ohtaki
Journal:  Pediatr Surg Int       Date:  2007-08-16       Impact factor: 1.827

7.  Chromosome telomere integrity of human solid neoplasms.

Authors:  M G Butler; M Sciadini; L K Hedges; H S Schwartz
Journal:  Cancer Genet Cytogenet       Date:  1996-01

8.  Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data.

Authors:  Matthew Parker; Xiang Chen; Armita Bahrami; James Dalton; Michael Rusch; Gang Wu; John Easton; Nai-Kong Cheung; Michael Dyer; Elaine R Mardis; Richard K Wilson; Charles Mullighan; Richard Gilbertson; Suzanne J Baker; Gerard Zambetti; David W Ellison; James R Downing; Jinghui Zhang
Journal:  Genome Biol       Date:  2012-12-11       Impact factor: 13.583

9.  Intratumoral diversity of telomere length in individual neuroblastoma tumors.

Authors:  Annalisa Pezzolo; Angela Pistorio; Claudio Gambini; Riccardo Haupt; Manuela Ferraro; Giovanni Erminio; Bruno De Bernardi; Alberto Garaventa; Vito Pistoia
Journal:  Oncotarget       Date:  2015-04-10

10.  Telomere length modulation in human astroglial brain tumors.

Authors:  Domenico La Torre; Alfredo Conti; M Hammed Aguennouz; Maria Grazia De Pasquale; Sara Romeo; Filippo Flavio Angileri; Salvatore Cardali; Chiara Tomasello; Concetta Alafaci; Antonino Germanò
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.